Takeda Pharmaceutical Co Ltd Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity

Takeda Pharmaceutical CO LTD is > 10% Shareholder of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 3.76 Million shares of PHAT, which is worth approximately $30.7 Million. The most recent transaction as insider was on Jan 24, 2024, when has been sold 3,703,703 shares (Common Stock) at a price of $8.1 per share, resulting in proceeds of $29,999,994. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.76M

0% 3M change

49.65% 12M change

Total Value Held $30.7 Million

TAKEDA PHARMACEUTICAL CO LTD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2024	SELL Open market or private sale	$29,999,994 $8.1 p/Share	3,703,703 Reduced 49.65%	3,755,583 Common Stock
Mar 14 2022	SELL Open market or private sale	$342 $19.0 p/Share	18 Reduced 0.0%	7,459,286 Common Stock
Mar 14 2022	BUY Exercise of in-the-money or at-the-money derivatives securities	-	7,359,304 Added 49.66%	7,459,304 Common Stock
Nov 04 2021	SELL Open market or private sale	$19,930,020 $19.93 p/Share	1,000,001 Reduced 90.91%	100,000 Common Stock
Nov 04 2021	BUY Exercise of in-the-money or at-the-money derivatives securities	-	228,696 Added 17.21%	1,100,001 Common Stock
Jul 07 2021	SELL Open market or private sale	$91,445 $35.05 p/Share	2,609 Reduced 0.3%	871,305 Common Stock
Jul 02 2021	SELL Open market or private sale	$3,501 $35.01 p/Share	100 Reduced 0.01%	873,914 Common Stock
Jul 01 2021	SELL Open market or private sale	$289,226 $35.16 p/Share	8,226 Reduced 0.93%	874,014 Common Stock
Jun 28 2021	SELL Open market or private sale	$12,980 $35.08 p/Share	370 Reduced 0.04%	882,240 Common Stock
Jun 25 2021	SELL Open market or private sale	$862,925 $35.76 p/Share	24,131 Reduced 2.66%	882,610 Common Stock
Jun 24 2021	SELL Open market or private sale	$381,199 $35.14 p/Share	10,848 Reduced 1.18%	906,741 Common Stock
Jun 23 2021	SELL Open market or private sale	$7,000 $35.0 p/Share	200 Reduced 0.02%	917,589 Common Stock
Jun 22 2021	SELL Open market or private sale	$3,500 $35.0 p/Share	100 Reduced 0.01%	917,789 Common Stock
Jun 21 2021	SELL Open market or private sale	$328,171 $35.31 p/Share	9,294 Reduced 1.0%	917,889 Common Stock
Jun 18 2021	SELL Open market or private sale	$189,632 $35.13 p/Share	5,398 Reduced 0.58%	927,183 Common Stock
Jun 17 2021	SELL Open market or private sale	$115,939 $35.08 p/Share	3,305 Reduced 0.35%	932,581 Common Stock
Jun 14 2021	SELL Open market or private sale	$99,080 $35.06 p/Share	2,826 Reduced 0.3%	935,886 Common Stock
Jun 10 2021	SELL Open market or private sale	$73,864 $35.14 p/Share	2,102 Reduced 0.22%	938,712 Common Stock
Jun 09 2021	SELL Open market or private sale	$42,018 $35.28 p/Share	1,191 Reduced 0.13%	940,814 Common Stock
Jun 08 2021	SELL Open market or private sale	$3,500 $35.0 p/Share	100 Reduced 0.01%	942,005 Common Stock
Jun 07 2021	SELL Open market or private sale	$79,353 $35.05 p/Share	2,264 Reduced 0.24%	942,105 Common Stock
Jun 02 2021	SELL Open market or private sale	$151,274 $35.18 p/Share	4,300 Reduced 0.45%	944,369 Common Stock
Jun 01 2021	SELL Open market or private sale	$402,251 $35.88 p/Share	11,211 Reduced 1.17%	948,669 Common Stock
May 28 2021	SELL Open market or private sale	$324,498 $36.44 p/Share	8,905 Reduced 0.92%	959,880 Common Stock
May 27 2021	SELL Open market or private sale	$315,043 $37.27 p/Share	8,453 Reduced 0.86%	968,785 Common Stock

Also insider at

THRX

Theseus Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

XLO

Xilio Therapeutics, Inc. Healthcare

> 10% Shareholder

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

CALA

Calithera Biosciences, Inc. Healthcare

OVID

Ovid Therapeutics Inc. Healthcare

> 10% Shareholder

HLVX

HilleVax, Inc. Healthcare

> 10% Shareholder

TPC